Thrivent Financial for Lutherans
EPIX

Thrivent Financial for Lutherans’s ESSA Pharma EPIX Stock Holding History

Thrivent Financial for Lutherans’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-33,389
Closed -$87K – 2457
2022
Q4 		$87K Buy
33,389
+2,052
+7% +$5.89K ﹤0.01% 2388
2022
Q3 		$56K Buy
+31,337
New +$82.6K ﹤0.01% 2390

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Thrivent Financial for Lutherans's EPIX Position: Q1 2023 in Review

Thrivent Financial for Lutherans sold out of ESSA Pharma (EPIX) in Q1 2023, closing a stake of 33,389 shares — an estimated $87K sold.

Thrivent Financial for Lutherans first reported a position in EPIX in Q3 2022 and held it in 2 quarters. The position peaked at $87K in Q4 2022. 37 funds tracked by Wall St. Rank hold EPIX as of Q1 2023.

  • Thrivent Financial for Lutherans reported no remaining ESSA Pharma position as of Q1 2023 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 33,389 ESSA Pharma shares in Q1 2023, an estimated $87K.
  • Thrivent Financial for Lutherans first reported a position in ESSA Pharma in Q3 2022 and held it in 2 quarters.
  • Thrivent Financial for Lutherans's ESSA Pharma position peaked at $87K in Q4 2022.
  • 37 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2023, filed 17 May 2023.